Assessment of the safety and efficiency of sunitinib malate in metastatic neuroendocrine tumours of the pancreas (NEN G1/G2) depending on the number and type of earlier therapeutic lines - initial report.
about
Assessment of the safety and efficiency of sunitinib malate in metastatic neuroendocrine tumours of the pancreas (NEN G1/G2) depending on the number and type of earlier therapeutic lines - initial report.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Assessment of the safety and e ...... peutic lines - initial report.
@en
Assessment of the safety and e ...... ocrine tumours of the pancreas
@nl
type
label
Assessment of the safety and e ...... peutic lines - initial report.
@en
Assessment of the safety and e ...... ocrine tumours of the pancreas
@nl
altLabel
Ocena bezpieczeństwa i efektyw ...... tycznych — doniesienie wstępne
@en
prefLabel
Assessment of the safety and e ...... peutic lines - initial report.
@en
Assessment of the safety and e ...... ocrine tumours of the pancreas
@nl
P50
P356
P1476
Assessment of the safety and e ...... apeutic lines - initial report
@en
P2093
Agnieszka Boratyn-Nowicka
Wojciech Rogowski
P304
P356
10.5603/EP.2014.0066
P50
P577
2014-01-01T00:00:00Z